Submission of Audited Financial Results for the quarter and year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 4.3 pts more than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Nexus Surgical and Medicare reported strong FY25 results with total income of Rs. 572.83 lakhs, up about 64% from Rs. 350.11 lakhs in FY24. Profit before tax nearly doubled to Rs. 66.79 lakhs from Rs. 29.07 lakhs, while profit after tax jumped to Rs. 49.74 lakhs from Rs. 21.33 lakhs — a rise of over 130%. Q4 FY25 was also strong with total income of Rs. 148.92 lakhs versus Rs. 59.33 lakhs a year earlier. The auditor issued an unqualified (unmodified) opinion, and the company swung its operating cash flow back into positive territory at Rs. 10.42 lakhs compared with a Rs. 41.40 lakh outflow in FY24.
Positive for shareholders — sharp revenue and profit growth, improving margins, and a turnaround in operating cash flow signal healthier business momentum. However, the company still carries negative other equity (reserves of Rs. -440.83 lakhs), which is a lingering concern despite the improved profitability.